We offer personalized weight management solutions based on your unique health needs and goals
There is evidence supporting the use of GLP-1 agonists for weight management in perimenopausal and postmenopausal women, particularly for obesity and metabolic disturbances associated with menopause
Obesity Med
Similar content being viewed by others Introduction Pentadecapeptide BPC 157 is known to possess therapeutic efficacy on variable tissue healing and angiogenesis that is considered through the activation of nitric oxide system as reported in previous studies 1,2,3,4,5,6
Animal studies Numerous research studies have been carried out in animal models (murine and farm animals) to investigate how LC and ALC improve female reproductive functions [16, 19, 21, 42,43,44] (Table 1)